Clinical Trials in Children
Participating in a clinical trial is an important and personal decision. That’s especially true when considering a study for a child. Pfizer is committed to improving the health and well-being of children through thoughtfully designed clinical trials.
The participants in these clinical studies help to improve the health of children around the world. Some pediatric clinical studies are designed to develop pediatric prescribing information for medicines already being used in adults. Others are specific to diseases that uniquely or especially impact the lives of children, such as those that prevent disease—like vaccines—or are related to genetic conditions.
Leadership in Pediatric Research
Every stage in a child’s development is unique, just as every child is special. In 2014, Pfizer formed the Pediatric Center of Excellence in order to better understand and meet the unique needs of children who are participating in clinical studies. We’re proud to partner with over 160 children’s hospitals and research centers chosen for their excellence and personal dedication to pediatric patients. This team combines the expertise and guidance of experienced pediatric physicians and researchers, child health advocates, parents, caregivers, and pediatric patients themselves. Today, those insights are at work in over 100 active or planned pediatric clinical studies as Pfizer continues to strive toward developing breakthroughs that change patients’ lives.